Roy C.

Roy C. is a Healthcare Private Equity Investor at ARCHIMED since September 2023, where the firm focuses on the healthcare sector and manages $8 billion across various funds. Prior to this role, Roy served as a Private Equity Associate at SFW Capital Partners, where investments were made in the life sciences and industrial technology sectors. Previous experience includes consulting for pharmaceutical and biotechnology firms at Oliver Wyman as part of the Health and Life Sciences group, an Analyst Intern position at Health Advances specializing in healthcare strategy, and a Business Development Intern role at PulsePoint, focusing on data-driven solutions for healthcare organizations. Additionally, Roy worked as a Research Assistant at The Johns Hopkins University, studying genetic mechanisms in the context of spermatogenesis. Roy holds a Bachelor's degree in Molecular and Cellular Biology and Business from The Johns Hopkins University.